Publication | Closed Access

Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas

Tumor BiologyDisease ProgressionOncogenic AgentMedicinePathologyBronchial NeoplasmLung AdenocarcinomasCancer GeneticsCancer BiologyCell BiologyLung CancerCancer ResearchLysyl Oxidase-like 2